Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Growth Metrics

Marimed (MRMD) Land & Improvements (2016)

Marimed has reported Land & Improvements over the past 2 years, most recently at $686802.0 for Q3 2016.

Quarterly Land & Improvements changed N/A to $686802.0 in Q3 2016 from the year-ago period, while the trailing twelve-month figure was $686802.0 through Sep 2016, changed N/A year-over-year, with the annual reading at $71488.0 for FY2015, N/A changed from the prior year.
Land & Improvements was $686802.0 for Q3 2016 at Marimed, up from $179196.0 in the prior quarter.
Over five years, Land & Improvements peaked at $686802.0 in Q3 2016 and troughed at $71488.0 in Q4 2015.